Radiotherapy-Induced Nausea and Vomiting Treatment Market Size, Share, and Growth Forecast 2026 - 2033

Table of Content

1. Executive Summary
   1. Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Snapshot 2026 and 2033
   2. Market Opportunity Assessment, 2026-2033, US$ Bn
   3. Key Market Trends
   4. Industry Developments and Key Market Events
   5. Demand Side and Supply Side Analysis
   6. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definitions
   2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
   3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Healthcare Expenditure
   4. Forecast Factors – Relevance and Impact
   5. COVID-19 Impact Assessment
3. Value Added Insights
   1. Value Chain analysis
   2. Key Market Players
   3. Treatment Adoption Analysis
   4. Key Promotional Strategies by key players
   5. PESTLE Analysis
   6. Porter's Five Forces Analysis
   7. Regulatory and Technology Landscape
4. Price Trend Analysis, 2025
   1. Region-wise Price Analysis
   2. Price by Segments
   3. Price Impact Factors
5. Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
   1. Key Highlights
   2. Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Treatment Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Treatment Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
         1. Preventive treatment
         2. Rescue treatment
      4. Market Attractiveness Analysis: Treatment Type
   3. Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Drug Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Drug Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
         1. Serotonin (5-HT3) receptor antagonists
         2. NK1 receptor antagonists
         3. Corticosteroids
         4. Others
      4. Market Attractiveness Analysis: Drug Type
   4. Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Distribution Channel
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Distribution Channel, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
         1. Hospital pharmacies
         2. Retail pharmacies
         3. Online pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
6. Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
   3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
   1. Key Highlights
   2. Pricing Analysis
   3. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
   4. North America Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Preventive treatment
      2. Rescue treatment
   5. North America Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Serotonin (5-HT3) receptor antagonists
      2. NK1 receptor antagonists
      3. Corticosteroids
      4. Others
   6. North America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital pharmacies
      2. Retail pharmacies
      3. Online pharmacies
8. Europe Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
   1. Key Highlights
   2. Pricing Analysis
   3. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Europe Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Preventive treatment
      2. Rescue treatment
   5. Europe Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Serotonin (5-HT3) receptor antagonists
      2. NK1 receptor antagonists
      3. Corticosteroids
      4. Others
   6. Europe Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital pharmacies
      2. Retail pharmacies
      3. Online pharmacies
9. East Asia Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
   1. Key Highlights
   2. Pricing Analysis
   3. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
   4. East Asia Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Preventive treatment
      2. Rescue treatment
   5. East Asia Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
      1. Serotonin (5-HT3) receptor antagonists
      2. NK1 receptor antagonists
      3. Corticosteroids
      4. Others
   6. East Asia Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital pharmacies
      2. Retail pharmacies
      3. Online pharmacies
10. South Asia & Oceania Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of SAO
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
       1. Preventive treatment
       2. Rescue treatment
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
       1. Serotonin (5-HT3) receptor antagonists
       2. NK1 receptor antagonists
       3. Corticosteroids
       4. Others
    6. South Asia & Oceania Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
       1. Hospital pharmacies
       2. Retail pharmacies
       3. Online pharmacies
11. Latin America Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
       1. Brazil
       2. Mexico
       3. Rest of LATAM
    4. Latin America Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
       1. Preventive treatment
       2. Rescue treatment
    5. Latin America Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
       1. Serotonin (5-HT3) receptor antagonists
       2. NK1 receptor antagonists
       3. Corticosteroids
       4. Others
    6. Latin America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
       1. Hospital pharmacies
       2. Retail pharmacies
       3. Online pharmacies
12. Middle East & Africa Radiotherapy-Induced Nausea and Vomiting Treatment Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
       1. GCC Countries
       2. South Africa
       3. Northern Africa
       4. Rest of MEA
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
       1. Preventive treatment
       2. Rescue treatment
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by Drug Type, 2026-2033
       1. Serotonin (5-HT3) receptor antagonists
       2. NK1 receptor antagonists
       3. Corticosteroids
       4. Others
    6. Middle East & Africa Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
       1. Hospital pharmacies
       2. Retail pharmacies
       3. Online pharmacies
13. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping
       2. Competition Dashboard
    3. Company Profiles
       1. Pfizer Inc.
          1. Company Overview
          2. Product Portfolio/Offerings
          3. Key Financials
          4. SWOT Analysis
          5. Company Strategy and Key Developments
       2. GlaxoSmithKline plc
       3. Merck & Co., Inc.
       4. Sanofi S.A.
       5. Novartis AG
       6. Teva Pharmaceutical Industries Ltd.
       7. Dr. Reddy’s Laboratories Ltd.
       8. Cipla Ltd.
       9. Mylan (Viatris)
       10. Qilu Pharma
       11. Taiji Group
       12. Helsinn Group
       13. Heron Therapeutics Inc.
       14. Kyowa Kirin Co., Ltd.
       15. Unimed Pharmaceuticals (AbbVie)
       16. Others
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations